Saccharomyces boulardii is a non-pathogenic probiotic yeast that survives stomach acid to nourish the intestines, support the immune system and provide a favorable growth environment for the beneficial bacteria that support health and digestive comfort. Medical studies have shown the efficacy and safety of S. boulardii for a number of health conditions in both adults and children. These applications include prevention of antibiotic-related diarrhea, recurrent C. difficile-related diarrhea and colitis, traveler's diarrhea, acute bacterial and viral diarrhea, inflammatory bowels and irritable bowels.
S. boulardii acts as a temporary flora that quickly achieves high concentrations in the GI tract. It is one of the few yeasts that survives best at human body temperatures and is able to colonize and persist in the gut.
Healthy gut flora protects against some infectious diarrheas. Antibiotic-associated diarrhea (AAD) is an example, as antibiotics deplete and disrupt the normal flora, and the resulting diarrhea may be due to changes in short chain fatty acid metabolism. A severe form of AAD is due to the pathogen Clostridium difficule. Recurrent C. difficile diarrhea is difficult to treat successfully as one recurrence makes further recurrences more probable, likely because antibiotics are needed to treat and thus the fecal flora remains imbalanced. Saccharomyces boulardii may be beneficial as an adjunct to antibiotics. Due to their fungal nature, the yeast cells of S. boulardii are antibiotic resistant.
Probiotic actions are strain specific and effectiveness of strains from the same species may be very different. S. boulardii is genetically and functionally distinct from brewer's yeast (S. cerevisiae) and different from pathogenic Candida species. Even though taxonomically assigned to the S. cerevisiae species, S. boulardii is characterized by a number of genetic features providing them to be more suitable to the intestinal environment. Patient One's S. boulardii strain is identified and verified through a combination of the most advanced genetic techniques.
Equally important to selecting an effective strain is selecting an effective preparation. Patient One's S. boulardii is obtained through a patented controlled-temperature, low-vacuum drying process. This technique preserves whole yeast cells and provides greater stability over time. Our product is encapsulated in a delayed release, acid-resistant vegetable capsule for effective delivery into the intestinal tract.
Patient One Saccharomyces boulardii provides a minimum of 5 Billion viable organisms per capsule at encasulation and is stable at room temperature, making it convenient for travel.